Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanny Chalmin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|June 9, 2021
Follicular helper-T cells restore CD8<sup>+</sup>-dependent antitumor immunity and anti-PD-L1/PD-1 efficacyJulie Niogret, Hélène Berger, Cédric Rebe, et al.
Cancer Research|April 27, 2013
SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growthHélène Berger, Frédérique Végran, Madijd Chikh, et al.
Cancer Immunology Research|January 9, 2021
The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of <i>Irf1</i> Pre-mRNAAntoine Bernard, Christophe Hibos, Corentin Richard, et al.
Immunity|March 13, 2012
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expressionFanny Chalmin, Grégoire Mignot, Mélanie Bruchard, et al.
Journal for Immunotherapy of Cancer|June 22, 2026
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapyMannon Geindreau, Cassandre Pignol, Loïs Coënon, et al.
Cancer Immunology Research|May 25, 2022
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor EffectsRomain Mary, Fanny Chalmin, Théo Accogli, et al.
The Journal of Clinical Investigation|January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsFanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Nature Communications|November 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancerAnaïs Perrichet, Julie Lecuelle, Emeric Limagne, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|June 9, 2021
Follicular helper-T cells restore CD8<sup>+</sup>-dependent antitumor immunity and anti-PD-L1/PD-1 efficacyJulie Niogret, Hélène Berger, Cédric Rebe, et al.
Cancer Research|April 27, 2013
SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growthHélène Berger, Frédérique Végran, Madijd Chikh, et al.
Cancer Immunology Research|January 9, 2021
The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of <i>Irf1</i> Pre-mRNAAntoine Bernard, Christophe Hibos, Corentin Richard, et al.
Immunity|March 13, 2012
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expressionFanny Chalmin, Grégoire Mignot, Mélanie Bruchard, et al.
Journal for Immunotherapy of Cancer|June 22, 2026
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapyMannon Geindreau, Cassandre Pignol, Loïs Coënon, et al.
Cancer Immunology Research|May 25, 2022
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor EffectsRomain Mary, Fanny Chalmin, Théo Accogli, et al.
The Journal of Clinical Investigation|January 23, 2010
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsFanny Chalmin, Sylvain Ladoire, Grégoire Mignot, et al.
Nature Communications|November 21, 2025
Cancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancerAnaïs Perrichet, Julie Lecuelle, Emeric Limagne, et al.
Pageof 3